Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use

Personalized dendritic cell- (DC-) based vaccination has proven to be safe and effective as second-line therapy against various cancer types. In terms of overall survival, there is still room for improvement of DC-based therapies, including the development of more immunostimulatory DC vaccines. In t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunol Res
Main Authors: Van den Bergh, J. M. J., Smits, E. L. J. M., Versteven, M., De Reu, H., Berneman, Z. N., Van Tendeloo, V. F. I., Lion, E.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5530419/
https://ncbi.nlm.nih.gov/pubmed/28785596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/1975902
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados